Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-12

Clinical Trial Update: IP-coated Revision Hip Implants [NA]

View source ↗

Summary

Aesculap AG is conducting a clinical trial evaluating IP-coated revision hip implants for prevention of peri-prosthetic joint infection, and the study is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IP-coated Revision Hip Implants

Snippet

Sponsor: Aesculap AG | Conditions: Peri-Prosthetic Joint Infection | NA | Status: RECRUITING